308 related articles for article (PubMed ID: 19810099)
1. Serum levels of IGF-I, IGFBP-3 and colorectal cancer risk: results from the EPIC cohort, plus a meta-analysis of prospective studies.
Rinaldi S; Cleveland R; Norat T; Biessy C; Rohrmann S; Linseisen J; Boeing H; Pischon T; Panico S; Agnoli C; Palli D; Tumino R; Vineis P; Peeters PH; van Gils CH; Bueno-de-Mesquita BH; Vrieling A; Allen NE; Roddam A; Bingham S; Khaw KT; Manjer J; Borgquist S; Dumeaux V; Torhild Gram I; Lund E; Trichopoulou A; Makrygiannis G; Benetou V; Molina E; Donate Suárez I; Barricarte Gurrea A; Gonzalez CA; Tormo MJ; Altzibar JM; Olsen A; Tjonneland A; Grønbaek H; Overvad K; Clavel-Chapelon F; Boutron-Ruault MC; Morois S; Slimani N; Boffetta P; Jenab M; Riboli E; Kaaks R
Int J Cancer; 2010 Apr; 126(7):1702-15. PubMed ID: 19810099
[TBL] [Abstract][Full Text] [Related]
2. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women.
Kaaks R; Toniolo P; Akhmedkhanov A; Lukanova A; Biessy C; Dechaud H; Rinaldi S; Zeleniuch-Jacquotte A; Shore RE; Riboli E
J Natl Cancer Inst; 2000 Oct; 92(19):1592-600. PubMed ID: 11018095
[TBL] [Abstract][Full Text] [Related]
3. Milk intake, circulating levels of insulin-like growth factor-I, and risk of colorectal cancer in men.
Ma J; Giovannucci E; Pollak M; Chan JM; Gaziano JM; Willett W; Stampfer MJ
J Natl Cancer Inst; 2001 Sep; 93(17):1330-6. PubMed ID: 11535708
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor (IGF)-I, IGF-II, IGF binding protein-3, and risk of colorectal cancer: a nested case-control study in the Japan Collaborative Cohort study.
Suzuki S; Kojima M; Tokudome S; Suzuki K; Ozasa K; Ito Y; Inaba Y; Tajima K; Nakachi K; Watanabe Y; Tamakoshi A;
Asian Pac J Cancer Prev; 2009 Dec; 10 Suppl():45-9. PubMed ID: 20553081
[TBL] [Abstract][Full Text] [Related]
5. Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study.
Stattin P; Bylund A; Rinaldi S; Biessy C; Déchaud H; Stenman UH; Egevad L; Riboli E; Hallmans G; Kaaks R
J Natl Cancer Inst; 2000 Dec; 92(23):1910-7. PubMed ID: 11106682
[TBL] [Abstract][Full Text] [Related]
6. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.
Ma J; Pollak MN; Giovannucci E; Chan JM; Tao Y; Hennekens CH; Stampfer MJ
J Natl Cancer Inst; 1999 Apr; 91(7):620-5. PubMed ID: 10203281
[TBL] [Abstract][Full Text] [Related]
7. Serum IGF-I, its major binding protein (IGFBP-3) and epithelial ovarian cancer risk: the European Prospective Investigation into Cancer and Nutrition (EPIC).
Peeters PH; Lukanova A; Allen N; Berrino F; Key T; Dossus L; Rinaldi S; van Gils CH; Bueno-de-Mesquita HB; Boeing H; Schulz M; Chang-Claude J; Linseisen J; Panico S; Sacerdote C; Palli D; Tumino R; Trichopoulou A; Trichopolos D; Bamia C; Larranaga N; Ardanaz E; Pera G; Quirós JR; Martínez-García C; Navarro C; Bingham SA; Khaw KT; Clavel F; Tjonneland A; Olsen A; Overvad K; Tetsche MS; Lund E; Lundin E; Berglund G; Riboli E; Kaaks R
Endocr Relat Cancer; 2007 Mar; 14(1):81-90. PubMed ID: 17395977
[TBL] [Abstract][Full Text] [Related]
8. IGF-1, IGF-2 and IGFBP-3 in prediagnostic serum: association with colorectal cancer in a cohort of Chinese men in Shanghai.
Probst-Hensch NM; Yuan JM; Stanczyk FZ; Gao YT; Ross RK; Yu MC
Br J Cancer; 2001 Nov; 85(11):1695-9. PubMed ID: 11742490
[TBL] [Abstract][Full Text] [Related]
9. Serum IGF-I, IGF-II, IGFBP-3, and IGF-I/IGFBP-3 molar ratio and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.
Douglas JB; Silverman DT; Pollak MN; Tao Y; Soliman AS; Stolzenberg-Solomon RZ
Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2298-306. PubMed ID: 20699371
[TBL] [Abstract][Full Text] [Related]
10. Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer.
Wolpin BM; Meyerhardt JA; Chan AT; Ng K; Chan JA; Wu K; Pollak MN; Giovannucci EL; Fuchs CS
J Clin Oncol; 2009 Jan; 27(2):176-85. PubMed ID: 19064975
[TBL] [Abstract][Full Text] [Related]
11. High-risk colorectal adenomas and serum insulin-like growth factors.
Renehan AG; Painter JE; Atkin WS; Potten CS; Shalet SM; O'Dwyer ST
Br J Surg; 2001 Jan; 88(1):107-13. PubMed ID: 11136321
[TBL] [Abstract][Full Text] [Related]
12. A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women.
Giovannucci E; Pollak MN; Platz EA; Willett WC; Stampfer MJ; Majeed N; Colditz GA; Speizer FE; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):345-9. PubMed ID: 10794477
[TBL] [Abstract][Full Text] [Related]
13. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
Schernhammer ES; Holly JM; Pollak MN; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):699-704. PubMed ID: 15767352
[TBL] [Abstract][Full Text] [Related]
14. Plasma C-peptide, insulin-like growth factor-I, insulin-like growth factor binding proteins and risk of colorectal cancer in a nested case-control study: the Japan public health center-based prospective study.
Otani T; Iwasaki M; Sasazuki S; Inoue M; Tsugane S;
Int J Cancer; 2007 May; 120(9):2007-12. PubMed ID: 17266031
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like Growth Factor-1, IGF-binding Protein-3, C-peptide and Colorectal Cancer: a Case-control Study.
Pankaj J; Kumari JR; Kim W; Lee SA
Asian Pac J Cancer Prev; 2015; 16(9):3735-40. PubMed ID: 25987030
[TBL] [Abstract][Full Text] [Related]
16. Serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 concentrations and prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition.
Allen NE; Key TJ; Appleby PN; Travis RC; Roddam AW; Rinaldi S; Egevad L; Rohrmann S; Linseisen J; Pischon T; Boeing H; Johnsen NF; Tjønneland A; Grønbaek H; Overvad K; Kiemeney L; Bueno-de-Mesquita HB; Bingham S; Khaw KT; Tumino R; Berrino F; Mattiello A; Sacerdote C; Palli D; Quirós JR; Ardanaz E; Navarro C; Larrañaga N; Gonzalez C; Sanchez MJ; Trichopoulou A; Travezea C; Trichopoulos D; Jenab M; Ferrari P; Riboli E; Kaaks R
Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1121-7. PubMed ID: 17548673
[TBL] [Abstract][Full Text] [Related]
17. [Study on the relations between serum insulin-like growth factor-1, insulin-like growth factor binding protein-3 and colorectal cancer: a meta-analysis].
Duan QH; Wang ZG; Zhu GB; Lu ZX; Shi LY; Nie SF
Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Feb; 26(2):132-4. PubMed ID: 15921617
[TBL] [Abstract][Full Text] [Related]
18. IGF-Binding Proteins, Adiponectin, and Survival in Metastatic Colorectal Cancer: Results From CALGB (Alliance)/SWOG 80405.
Guercio BJ; Zhang S; Ou FS; Venook AP; Niedzwiecki D; Lenz HJ; Innocenti F; Pollak MN; Nixon AB; Mullen BC; O'Neil BH; Shaw JE; Polite BN; Benson AB; Atkins JN; Goldberg RM; Brown JC; O'Reilly EM; Mayer RJ; Blanke CD; Fuchs CS; Meyerhardt JA
JNCI Cancer Spectr; 2021 Feb; 5(1):. PubMed ID: 33426464
[TBL] [Abstract][Full Text] [Related]
19. [Association of insulin, insulin-like growth factor and insulin-like growth factor binding proteins with the risk of colorectal cancer].
Jiang B; Liu DB; Zhang X; DU LL; Han CZ
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 May; 12(3):264-8. PubMed ID: 19434535
[TBL] [Abstract][Full Text] [Related]
20. Serum insulin-like growth factor I: tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men.
Woodson K; Tangrea JA; Pollak M; Copeland TD; Taylor PR; Virtamo J; Albanes D
Cancer Res; 2003 Jul; 63(14):3991-4. PubMed ID: 12873996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]